2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide

C25H26N4O4 — CID 3854322

IUPAC2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide
SMILESO=C(NC1CCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C2C1)C(O)c1ccccc1
InChIInChI=1S/C25H26N4O4/c30-22(15-6-2-1-3-7-15)24(32)27-17-10-11-29-21(13-17)23(31)28-20(25(29)33)12-16-14-26-19-9-5-4-8-18(16)19/h1-9,14,17,20-22,26,30H,10-13H2,(H,27,32)(H,28,31)
InChIKeyIPMCINSQYCRLIS-UHFFFAOYSA-N
MW446.51 g/mol
LogP1.42
Rot. Bonds5

About 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide

2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide (PubChem CID 3854322) has the molecular formula C25H26N4O4 and a molecular weight of 446.51 g/mol. Its IUPAC name is 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide.

Molecular Properties

Compound Name2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide
PubChem CID3854322
Molecular FormulaC25H26N4O4
Molecular Weight446.51 g/mol
Exact Mass446.20
IUPAC Name2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide
SMILESO=C(NC1CCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C2C1)C(O)c1ccccc1
InChIInChI=1S/C25H26N4O4/c30-22(15-6-2-1-3-7-15)24(32)27-17-10-11-29-21(13-17)23(31)28-20(25(29)33)12-16-14-26-19-9-5-4-8-18(16)19/h1-9,14,17,20-22,26,30H,10-13H2,(H,27,32)(H,28,31)
InChIKeyIPMCINSQYCRLIS-UHFFFAOYSA-N
XLogP1.42
TPSA114.53 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500446.51
LogP ≤ 51.42
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Analyze 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide?
The IUPAC name of 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide (CID 3854322) is 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide.
What is the SMILES notation for 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide?
The canonical SMILES for 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide is O=C(NC1CCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C2C1)C(O)c1ccccc1.
What is the InChIKey of 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide?
The InChIKey is IPMCINSQYCRLIS-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26N4O4/c30-22(15-6-2-1-3-7-15)24(32)27-17-10-11-29-21(13-17)23(31)28-20(25(29)33)12-16-14-26-19-9-5-4-8-18(16)19/h1-9,14,17,20-22,26,30H,10-13H2,(H,27,32)(H,28,31).
What are the key properties of 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide?
2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide has a molecular weight of 446.51 g/mol, XLogP of 1.42, 5 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-hydroxy-N-[3-(1H-indol-3-ylmethyl)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazin-8-yl]-2-phenylacetamide is sourced from PubChem (CID 3854322), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).